On Tuesday, Medtronic revealed it had acquired Sapiens Steering Brain Stimulation, a Dutch company developing brain stimulation technologies, for approximately $200 million in cash.
On Wednesday, the medical device company announced it had acquired NGC Medical S.p.A for $350 million. NGC is an Italian company that manages cardiovascular suites, operating rooms and intensive care units for hospitals.
Additionally, earlier this year, Medtronic acquired Irish device manufacturer Covidien for $42.9 billion.
An Associated Press report suggests the acquisitions of overseas companies are part of an inversion plan that allows the company to pay fewer corporate taxes.
More articles on aquisitions:
What Cerner’s acquisition of Siemens Health Services will mean for the health IT market
Covidien to acquire Reverse Medical
Roche to buy InterMune for $8.3B
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
